Radiat Oncol J.
2016 Jun;34(2):81-87. 10.3857/roj.2016.01697.
Hypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgery
- Affiliations
-
- 1Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea. radiat@snu.ac.kr
- 2Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.
- KMID: 2327380
- DOI: http://doi.org/10.3857/roj.2016.01697
Abstract
- Hypofractionated whole breast irradiation (HF-WBI) has been proved effective and safe and even better for late or acute radiation toxicity for early breast cancer. Moreover, it improves patient convenience, quality of life and is expected to be advantageous in the medical care system by reducing overall cost. In this review, we examined key randomized trials of HF-WBI, focusing on adequate patient selection as suggested by the American Society of Therapeutic Radiology and Oncology (ASTRO) guideline and the radiobiologic aspects of HF-WBI in relation to its adoption into clinical settings. Further investigation to identify the current practice pattern or cost effectiveness is warranted under the national health insurance service system in Korea.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Radiation Therapy for Patiens with Early-Stage Breast Carcinoma Treated with Breast-Conserving Surgery
- Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer
- Breast-Conserving Surgery With or Without Radiation Therapy for Early Breast Cancer
- Hypofractionated Partial Breast Irradiation With Intensity-Modulated Radiotherapy in Early Breast Cancer or Carcinoma In Situ: An Investigational Short-Term Analysis
- Comparison of Psychiatric Symptoms between Total Mastectomy and Breast Conserving Surgery in Breast Cancer Patients
